Schizophrenia
Item
participants who are diagnosed with schizophrenia (diagnosis criteria: diagnostic and statistical manual of mental disorders, fourth edition [dsm-iv])
boolean
C0036341 (UMLS CUI [1])
Patient need for Change Antipsychotic Agent | Etiology aspects | Lack of Efficacy | Intolerance to substance | Medication Compliance Lacking
Item
participants who need to change the antipsychotic drug to another one for the following reasons among the participants treated with an antipsychotic drug for more than two weeks before the screening-lack of efficacy, lack of tolerance or lack of compliance
boolean
C0686904 (UMLS CUI [1,1])
C0392747 (UMLS CUI [1,2])
C0040615 (UMLS CUI [1,3])
C0015127 (UMLS CUI [2])
C0235828 (UMLS CUI [3])
C1744706 (UMLS CUI [4])
C3489773 (UMLS CUI [5,1])
C0332268 (UMLS CUI [5,2])
Questionnaire Completion
Item
participants who are capable of and willing to fill out the questionnaire for themselves
boolean
C0034394 (UMLS CUI [1,1])
C0205197 (UMLS CUI [1,2])
Childbearing Potential Contraceptive methods | Contraceptives, Oral | Contraceptive injection | Intrauterine Devices | Barrier Contraception Double | Contraceptive patch
Item
childbearing potential women who consent to the use of the consistently permissible contraception (oral contraceptive, contraceptive injection, intrauterine device, double barrier method and contraceptive patch)
boolean
C3831118 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C0009905 (UMLS CUI [2])
C1656586 (UMLS CUI [3])
C0021900 (UMLS CUI [4])
C0004764 (UMLS CUI [5,1])
C0205173 (UMLS CUI [5,2])
C2985284 (UMLS CUI [6])
Compliance behavior Self Medication | Ability Receive Support
Item
participants who are compliant with self-medication or can receive consistent help or support
boolean
C1321605 (UMLS CUI [1,1])
C0036600 (UMLS CUI [1,2])
C0085732 (UMLS CUI [2,1])
C1514756 (UMLS CUI [2,2])
C1521721 (UMLS CUI [2,3])
Neuroleptic Malignant Syndrome | Risperidone allergy | Hypersensitivity paliperidone
Item
participants with the past history of neuroleptic malignant syndrome (nms), or with allergy or hypersensitivity to risperidone or paliperidone
boolean
C0027849 (UMLS CUI [1])
C0570837 (UMLS CUI [2])
C0020517 (UMLS CUI [3,1])
C0753678 (UMLS CUI [3,2])
Clozapine
Item
participants who have taken clozapine within one month before screening
boolean
C0009079 (UMLS CUI [1])
At risk for suicide | At risk Aggressive behavior | Completion of clinical trial Unable
Item
participants who are suspicious of having clinically significant risk including suicide or aggressive behavior and are expected to unable to complete the study (based on the investigator's judgment)
boolean
C0563664 (UMLS CUI [1])
C1444641 (UMLS CUI [2,1])
C0001807 (UMLS CUI [2,2])
C2732579 (UMLS CUI [3,1])
C1299582 (UMLS CUI [3,2])
Gastrointestinal stenosis Severe Pre-existing | Gastrointestinal stenosis Severe Pre-existing Iatrogenic | Lacking Able to swallow Investigational New Drug
Item
participants with severe preexisting gastrointestinal narrowing (pathologic or iatrogenic) or participants who cannot swallow the drug whole (the study drug must not be chewed, divided, melted or grinded because it can impact the study drug release profile)
boolean
C0521587 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C2347662 (UMLS CUI [1,3])
C0521587 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C2347662 (UMLS CUI [2,3])
C0439669 (UMLS CUI [2,4])
C0332268 (UMLS CUI [3,1])
C2712086 (UMLS CUI [3,2])
C0013230 (UMLS CUI [3,3])
Substance Dependence | Substance Dependence Suspected
Item
participants with a known or suspected history (for 6 months and longer) of substance dependence according to the dsm-iv criteria
boolean
C0038580 (UMLS CUI [1])
C0038580 (UMLS CUI [2,1])
C0750491 (UMLS CUI [2,2])